Patents Assigned to Abbott Laboratories
  • Publication number: 20190014793
    Abstract: Disclosed are methods of providing nutrition to infants, as well as sterilized liquid protein supplements including extensively hydrolyzed casein for use with human milk and other infant feeding formulas. The sterilized liquid protein supplements have a low pH, thereby inhibiting protein denaturation and reducing microbial growth.
    Type: Application
    Filed: September 19, 2018
    Publication date: January 17, 2019
    Applicant: ABBOTT LABORATORIES
    Inventors: CATHERINE S. LAMB, STEVEN T. LUEBBERS, KANDICE T. TUCKER, PAUL W. JOHNS, BRIDGET BARRETT-REIS
  • Publication number: 20190014807
    Abstract: Disclosed embodiments provide nutritional compositions and methods of enhancing maturation of an infant's brain. The methods include the step of administering to the infant a nutritional composition comprising a protein with a degree of hydrolysis of 10% to 75% in combination with at least one of a monoglyceride, a free fatty acid, a salt of a free fatty acid, a phospholipid, and cholesterol.
    Type: Application
    Filed: December 27, 2016
    Publication date: January 17, 2019
    Applicant: ABBOTT LABORATORIES
    Inventors: TAPAS DAS, MUSTAFA VURMA, CHRON-SI LAI, PAUL JOHNS
  • Publication number: 20190008182
    Abstract: Abstract: A method of preparing a protein hydrolysate using extrusion technology is provided. An intact protein source and a protease component are added to an extruder and mixed therein to form a slurry including a protein hydrolysate having a degree of hydrolysis of 5% to 30%. The slurry has a total protein content of at least 30% based on the weight of solids in the slurry. A protein hydrolysate accordingly produced is also claimed.
    Type: Application
    Filed: December 29, 2016
    Publication date: January 10, 2019
    Applicant: Abbott Laboratories
    Inventors: Laleh LOGHAVI, Gul KONUKLAR
  • Publication number: 20190000913
    Abstract: Disclosed embodiments provide a method of enhancing maturation of a lung, brain, or both, in an infant. The method includes the step of administering to the infant a nutritional composition comprising a protein with a degree of hydrolysis of 10% to 75%. Also disclosed are methods for reducing the incidence of necrotizing enterocolitis in an individual. In addition, the disclosed embodiments provide a method for the prevention, delay of progression, or the treatment of a circulatory disorder characterized by inadequate blood flow to the brain or lung.
    Type: Application
    Filed: December 27, 2016
    Publication date: January 3, 2019
    Applicant: ABBOTT LABORATORIES
    Inventors: TAPAS DAS, MUSTAFA VURMA, CHRON-SI LAI, PAUL JOHNS
  • Publication number: 20190004041
    Abstract: Provided herein are assays and kits useful for avoiding “prozone phenomenon” or “hook effect” and which expand the range of accurately measurable analyte concentrations.
    Type: Application
    Filed: August 8, 2018
    Publication date: January 3, 2019
    Applicant: ABBOTT LABORATORIES
    Inventors: Barry L. DOWELL, Susan GAYDA, Qiaoqiao RUAN, Joseph P. SKINNER, Sergey Y. TETIN
  • Patent number: 10166131
    Abstract: Stent delivery system having a contracted delivery configuration and an expanded deployed configuration is provided. The stent delivery system includes a stent having a plurality of expandable elements and a plurality of interstices disposed between adjacent expandable elements, and a delivery catheter having an inflatable balloon including creases extending non-uniformly within the interstices of the stent in the contracted delivery configuration. Each crease defines a maximum radial height within a corresponding interstice, and the maximum radial heights of the creases vary. A method for stenting at a target site within a patient's vessel including providing a stent delivery system is also provided.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: January 1, 2019
    Assignee: ABBOTT LABORATORIES VASCULAR ENTERPRISES LIMITED
    Inventors: Michael Schwager, Martin Frei, Suk-Woo Ha
  • Patent number: 10155225
    Abstract: A reagent manager for a diagnostic analyzer system includes a reagent manager housing, a high-speed reagent bottle spinning device, a processor, and a memory. The reagent manager housing is for housing reagent bottles. The high-speed reagent bottle spinning device is disposed within the reagent manager housing for spinning at least one of the reagent bottles. The processor is in electronic communication with the high-speed reagent bottle spinning device. The memory is in electronic communication with the processor. The memory includes programming code for execution by the processor. The programming code is configured to spin the high-speed reagent bottle spinning device to spin the at least one reagent bottle to remove microparticles from a bottom surface of a septum of the at least one reagent bottle.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: December 18, 2018
    Assignee: ABBOTT LABORATORIES
    Inventors: Joseph P. Donohue, Surya Pratap Rai
  • Patent number: 10144013
    Abstract: A centrifuge to which sample tubes can be introduced while the centrifuge is in motion. The centrifuge comprises a carousel having an upper portion and a lower portion. The upper portion of the carousel has a plurality of positions for sample tubes for a centrifugation operation, a plurality of drive mechanisms attached to the upper portion of the carousel, a movable element mounted upon each drive mechanism, the movable element capable of traversing the length of the drive mechanism when the drive mechanism is actuated, a sample tube-holding assembly comprising a sample tube holder and a bearing attached to each movable element, and at least one balancing element capable of contributing to a force vector that cancels an imbalance vector generated by rotation of the centrifuge.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: December 4, 2018
    Assignee: Abbott Laboratories
    Inventor: Patrick P. Fritchie
  • Patent number: 10143463
    Abstract: A method for closing a tissue puncture, where the method includes tensioning a suture loop disposed within a vascular tissue of a patient, the suture loop having two free ends and a knot disposed on one of the free end. Those two free ends are disposed through a suture snare comprising a snare. Following detachment of the suture snare from the two free ends, the knot is advanced to close the suture loop and a cutting member is advance towards the knot and the two free ends are cut.
    Type: Grant
    Filed: April 25, 2016
    Date of Patent: December 4, 2018
    Assignee: ABBOTT LABORATORIES
    Inventors: Mike S. Dana, Rob M. George, T. Daniel Gross, Maurice Marthaler, Dawn Ma, Jim Swett
  • Publication number: 20180279662
    Abstract: A nutritional supplement powder and method of supplementing the nutritional value of a food or beverage is provided. The nutritional supplement powder includes a protein system, vitamins, minerals, and fiber. The protein system has a water solubility of at least about 70% at room temperature. The nutritional supplement powder is essentially free of divalent ions of copper, iron, and zinc, and is also essentially free of vitamin C. When added to a food or beverage, the nutritional supplement powder does not substantially change the organoleptic properties of the food or beverage.
    Type: Application
    Filed: April 10, 2018
    Publication date: October 4, 2018
    Applicant: ABBOTT LABORATORIES
    Inventors: ROCKENDRA GUPTA, GAURAV PATEL, NORMANELLA DEWILLE
  • Patent number: 10088483
    Abstract: The present disclosure provides methods, kits, and compositions for detecting subject anti-HCV antibodies in a sample using NS3 capture peptides. In certain embodiments, at least two NS3 helicase (NS3h) capture peptides and at least two conjugate peptides (e.g., NS3h conjugate peptides) are employed together, which allows for a broad dynamic range of subject antibody detection in a one-step type assay. In other embodiments, methods are provided of detecting NS3-specific subject antibodies without the use of a reducing agent. In some embodiments, NS3-specific subject antibodies are detected with a ‘double shot’ of NS3 conjugate peptide (e.g., conjugate peptide added to a sample both before and after washing).
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: October 2, 2018
    Assignee: Abbott Laboratories
    Inventors: Anthony S. Muerhoff, John Prostko, Chris Marohnic
  • Patent number: 10085753
    Abstract: A method for delivering a closure element to an opening formed in a wall of a body lumen. The method includes inserting a distal end region of an apparatus into the opening in the wall of the body lumen, moving a third grasping portion toward the first grasping portion to limit movement of the distal end of the apparatus relative to the opening in the wall of the body lumen, and moving a second grasping portion toward the first grasping portion to advance the closure element distally. The second grasping portion and third grasping portion are movable toward the first grasping portion.
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: October 2, 2018
    Assignee: ABBOTT LABORATORIES
    Inventors: Erik K. Walberg, Timothy C. Reynolds, Brian A. Ellingwood, Kai Yenkai Jair, Anthony J. Pantages
  • Publication number: 20180256536
    Abstract: Methods for improving the visual processing of a healthy infant by administering a composition comprising RRR-alpha-tocopherol to the infant are disclosed. Methods for improving the visual acuity of a healthy infant by administering a composition comprising RRR-alpha-tocopherol to the infant are also disclosed. Methods for improving the development of the visual processing, visual acuity, or both, of an infant by administering a composition comprising RRR-alpha-tocopherol to the infant are also disclosed.
    Type: Application
    Filed: May 11, 2018
    Publication date: September 13, 2018
    Applicant: ABBOTT LABORATORIES
    Inventors: MATTHEW KUCHAN, CHRON-SI LAI, JACQUELINE BOFF
  • Patent number: 10073090
    Abstract: Provided herein are assays and kits useful for avoiding “prozone phenomenon” or “hook effect” and which expand the range of accurately measurable analyte concentrations.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: September 11, 2018
    Assignee: ABBOTT LABORATORIES
    Inventors: Barry L. Dowell, Susan Gayda, Qiaoqiao Ruan, Joseph P. Skinner, Sergey Y. Tetin
  • Publication number: 20180250258
    Abstract: Liquid nutritional compositions that include functional ingredients such as beta-hydroxy-beta-methylbutyrate, docosahexaenoic acid, and lutein are disclosed. The nutritional compositions are useful to promote at least one of physical performance (e.g., body composition, muscle mass, muscle strength) and cognitive function (e.g., focus, attention, alertness, executive function) in an individual. The functional ingredients are incorporated into the nutritional composition in such a way that they do not adversely affect the desirable properties of the nutritional composition such as, for example, nutritional value, stability, solubility, taste, and mouthfeel.
    Type: Application
    Filed: September 13, 2016
    Publication date: September 6, 2018
    Applicant: Abbott Laboratories
    Inventors: Guarav PATEL, Tapas DAS, Rockendra GUPTA
  • Patent number: D831488
    Type: Grant
    Filed: November 1, 2017
    Date of Patent: October 23, 2018
    Assignee: Abbott Laboratories
    Inventors: Margaret Reeber, Christina Cartwright, Jeremy McBroom, Michael Lorenz, Ross Worden
  • Patent number: D837053
    Type: Grant
    Filed: March 7, 2017
    Date of Patent: January 1, 2019
    Assignee: Abbott Laboratories
    Inventors: James Perry, Matthew L. Phillips, David Schweitzer, Robert Bruno
  • Patent number: D837401
    Type: Grant
    Filed: March 22, 2016
    Date of Patent: January 1, 2019
    Assignee: Abbott Laboratories
    Inventors: Gregory E. Gardner, Roger Simonsen, Douglas Campbell
  • Patent number: D835984
    Type: Grant
    Filed: March 7, 2017
    Date of Patent: December 18, 2018
    Assignee: Abbott Laboratories
    Inventors: James Perry, Jameel Ahmed, Matthew L. Phillips, David Schweitzer, Robert Bruno
  • Patent number: D838613
    Type: Grant
    Filed: April 27, 2017
    Date of Patent: January 22, 2019
    Assignee: Abbott Laboratories
    Inventors: Christina A. Barton, Rachel Elizabeth Wallace, Ami Marie Verhalen, Daniel Roger Nett